MedPath

Injectable 2% Hyaluronic acid vs i-PRF for reconstruction of lost interdental papilla.

Not Applicable
Conditions
Health Condition 1: K055- Other periodontal diseasesHealth Condition 2: K055- Other periodontal diseases
Registration Number
CTRI/2023/07/055307
Lead Sponsor
Mohammed Ashif
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Systemically healthy participants.

2.Class I or class II papilla according to Nordland and Tarnowâ??s Classification system for loss of papillary height.

3.Loe and Silness gingival index less than or equal to 1.

Exclusion Criteria

1. Participants using any form of tobacco.

2. Pregnant or lactating females.

3. Participants who are already on anti-inflammatory or anti-bacterial drugs.

4. Participants using a drug which has influence in gingival growth.

5. Participants with midline diastema / loss of proximal contact.

6. Participants with untreated maxillary anterior caries, prosthesis and orthodontic appliances.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the amount of papillary fill in the maxillary anterior region in the following groups of participants at the end of 3rd month, <br/ ><br>Group 1 with 2% Hyaluronic Acid <br/ ><br>Group 2 with i-PRF.Timepoint: Baseline, at the end of 1 month and at the end of 3rd month.
Secondary Outcome Measures
NameTimeMethod
To compare the effectiveness of 2% HA and i-PRF in the reconstruction of lost interdental papilla.Timepoint: At baseline, endo of 1st and 3rd month;To evaluate the effectiveness of injectable platelet-rich fibrin (i-PRF) in the reconstruction of lost interdental papilla.Timepoint: At baseline, end of 1st and 3rd month
© Copyright 2025. All Rights Reserved by MedPath